DE1411025U - - Google Patents

Info

Publication number
DE1411025U
DE1411025U DENDAT1411025D DE1411025DU DE1411025U DE 1411025 U DE1411025 U DE 1411025U DE NDAT1411025 D DENDAT1411025 D DE NDAT1411025D DE 1411025D U DE1411025D U DE 1411025DU DE 1411025 U DE1411025 U DE 1411025U
Authority
DE
Germany
Prior art keywords
quot
lfr1í
prr
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DENDAT1411025D
Other languages
German (de)
English (en)
Publication of DE1411025U publication Critical patent/DE1411025U/de
Active legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DENDAT1411025D Active DE1411025U (enExample)

Publications (1)

Publication Number Publication Date
DE1411025U true DE1411025U (enExample)

Family

ID=721444

Family Applications (1)

Application Number Title Priority Date Filing Date
DENDAT1411025D Active DE1411025U (enExample)

Country Status (1)

Country Link
DE (1) DE1411025U (enExample)

Similar Documents

Publication Publication Date Title
Gould et al. Virulent Newcastle disease in Australia: molecular epidemiological analysis of viruses isolated prior to and during the outbreaks of 1998–2000
Donis et al. Distinct lineages of influenza virus H4 hemagglutinin genes in different regions of the world
Guan et al. H5N1 influenza viruses isolated from geese in Southeastern China: evidence for genetic reassortment and interspecies transmission to ducks
Greck et al. Electrophilic amination: new synthetic applications
YU18593A (sh) Sredstva protiv gljivičnih oboljenja koja sadrže ciklični peptid i postupak za njihovo dobijanje
SE9604341D0 (sv) Hepta-peptide oxytocin analogue
US20020037860A1 (en) Method for reducing or preventing the establishment, growth or metastasis of cancer by administering indazole peptidomimetics PAR-1 antagonist and optionally PAR-2 antagonists
DE69629375T2 (de) Kodierte reaktionskassette
Locke et al. Newcastle disease virus phosphoprotein gene analysis and transcriptional editing in avian cells
HU205146B (en) Process for producing teicoplanine amide derivatives and pharmaceutical compositions comprising same
DE60132177T2 (de) Aminosäure-derivate als hiv aspartyl-protease-inhibitoren
DE1411025U (enExample)
Werth Isozyme studies on the Dryopteris" spinulosa" complex, I: The origin of the log fern Dryopteris celsa
CZ23397A3 (en) Derivatives of parathormone and parathormone related peptide, process of their preparation and pharmaceutical compositions containing thereof
CY1105796T1 (el) Θepαπεια οξεωσης της μεγαλης κοιλιας των μηρυκαστικων με αναστολεις αλφα-αμυλασης
JP2006158399A5 (ja) 細胞増殖抑制タンパク質並びにそれを用いる細胞増殖抑制剤、癌診断薬及び癌治療剤
HILL et al. Synthetic DNA probes for the identification of sibling species in the Anopheles gambiae complex
Toda et al. Regional and species differences in the response of isolated arteries to angiotensin II
JPH069628A (ja) ヒドロキシエチレン等量型のジチオラニルグリシン−含有hivプロテアーゼインヒビター
Van Berlo et al. Intracellular equine arteritis virus (EAV)-specific RNAs contain common sequences
Awata et al. Assignment of the tenascin gene (HXB) to swine chromosome 1q21. 1→ q21. 3 by fluorescence in situ hybridization
Aiglstorfer et al. NPY Y1 antagonists: structure–activity relationships of arginine derivatives and hybrid compounds with arpromidine-like partial structures
EP0183245A3 (en) Animal growth promotant
EP0094815A2 (en) Oligopeptide prodrugs
NO860624L (no) Acylerte heksosederivater og fremgangsmaater til fremstilling derav.